中鋼天源(002057.SZ):入選國企改革“科改示範行動”企業
格隆匯3月4日丨中鋼天源(002057.SZ)公佈,近日,國務院國有企業改革領導小組辦公室下發《關於做好“科改示範行動”入選企業改革方案備案等有關事項的通知》(國企改辦〔2020〕1號),初步確定將208户科技型企業納入“百户科技型企業深化市場化改革提升自主創新能力專項行動”。其中,公司入選國資改革“科改示範行動。
公司將按通知要求,認真制定改革方案和工作台賬,明確具體改革目標、改革舉措、責任分工、進度安排等,做到改革目標明確可考核,堅持以上率下、統籌推進改革,要進一步加強黨建,提升自主創新能力,着力完善公司治理,加快完善市場化選人用人機制,用好用足各項激勵政策,通過各項改革措施推動公司高質量發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.